February 18, 2026

FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer

FDA: Device Delivers Non-invasive Therapy and Supports Care at Home White Oak, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult patients with locally advanced pancreatic...

recent articles

Join us for a complimentary joint Visiopharm & Ultivue webinar! Advanced Phenotyping of the Tumor Immune Microenvironment MAY 26, 2021 | 9:00AM (PDT) | 12:00PM (EDT) | 6:00PM (CET) Register Now Immunotherapy has transformed the...

We are proud to announce the launch of OracleBio’s GCP Image Analysis Services.  Our new service offering generates quantitative image analysis data using a workflow that is conducted in accordance with GCP principles. This provides...

3DHISTECH proudly invites you to its Virtual Symposium – Digital Solutions for Research Microscopy, to be held online at 1pm CEST on May 26, 2021. The event will be streamed live on the 3DHISTECH YouTube channel. Participation is...

Helsinki, Finland - Aiforia is currently recruiting for multiple positions. Who is Aiforia? Aiforia equips pathologists and scientists in pre-clinical, academic, and clinical labs with the most powerful deep learning artificial intelligence...

Join Dr. Nguyen from University of Montreal Hospital Centre (CHUM) on May the 25th at 11am EST to hear about CHUM’s implementation process & benefits of digital pathology for routine diagnosis. Dr Nguyen is Professor of Pathology at...

Hemel Hempstead based company FFEI, has been honoured with their 4th Queen’s Award for Enterprise recognising their Digital Micro Imaging System for Pathology. FFEI Ltd, the global developer of award-winning digital imaging...

OR

platinum partners

gold partners

Silver Partners

Media Partners